Independent
Tenure on this board
5.3 yrs
Also a director at
Quince Therapeutics Inc (QNCX)
3 nominees · 5 ballot items.
The items on the ballot are the election of directors (Class I nominees), ratification of the independent auditor Ernst & Young LLP, advisory Say-on-Pay vote for named executive officers, an amendment to the Certificate of Incorporation to effect a reverse stock split if necessary to regain Nasdaq compliance (range 1-for-2 to 1-for-20), and an adjournment of the annual meeting to solicit additional proxies.
Election of three Class I directors: June Bray, Sandeep Laumas, M.D., and David Mack, to hold office until the 2028 annual meeting and until their successors are elected and qualified.
Ratify Ernst & Young LLP as the Company's independent registered public accounting firm for 2025.
Advisory vote to approve the compensation of the company's named executive officers as disclosed in the Proxy Statement.
Amendment to the Amended and Restated Certificate of Incorporation to authorize a reverse stock split not less than 1-for-2 and not more than 1-for-20 within 12 months following stockholder approval, to regain Nasdaq Minimum Bid Price requirements; exact ratio within Board's discretion.
Authorization of one or more adjournments of the Annual Meeting to solicit additional proxies in the event there are insufficient votes to approve Proposal 4.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 6.27% | 1,936,760 | $3M |
| 2 | ARMISTICE CAPITAL, LLC | 6.19% | 1,910,076 | $3M |
| 3 | OAKTREE CAPITAL MANAGEMENT LPActivist | 0.78% | 241,188 | $323K |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 0.67% | 207,339 | $278K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.61% | 189,806 | $255K |
| 6 | JONES FINANCIAL COMPANIES LLLP | 0.43% | 131,789 | $166K |
| 7 | Man Group plc | 0.31% | 96,473 | $129K |
| 8 | STATE STREET CORP | 0.30% | 92,118 | $123K |
| 9 | FMR LLC | 0.29% | 90,300 | $121K |
| 10 | VANGUARD FIDUCIARY TRUST CO | 0.28% | 84,921 | $114K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.